METHODS AND COMPOSITIONS FOR TREATING CANCER WITH ECM-AFFINITY PEPTIDES LINKED TO IMMUNOTHERAPEUTIC ANTIBODIES

The methods and compositions described herein address the need in the art by providing compositions and methods for a therapy with an antibody that is specifically targeted to and/or retained intra- or peri-tumorally, limiting systemic exposure and reducing side-effects. Accordingly, aspects of the...

Full description

Saved in:
Bibliographic Details
Main Authors ISHIHARA Jun, HUBBELL Jeffrey A, SWARTZ Melody, ISHIHARA Ako, FUKUNAGA Kazuto
Format Patent
LanguageEnglish
Spanish
Published 28.07.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The methods and compositions described herein address the need in the art by providing compositions and methods for a therapy with an antibody that is specifically targeted to and/or retained intra- or peri-tumorally, limiting systemic exposure and reducing side-effects. Accordingly, aspects of the disclosure relate to a composition comprising an immunotherapeutic antibody operatively linked to an extracellular matrix (ECM)-affinity peptide. An ECM-affinity peptide is one that has affinity for an extracellular matrix protein. Los métodos y composiciones descritos en la presente abordan la necesidad en la técnica al proporcionar composiciones y métodos para una terapia con un anticuerpo que está específicamente dirigido y/o retenido intratumoralmente o peritumoralmente, limitando la exposición sistémica y reduciendo los efectos secundarios. Por consiguiente, los aspectos de la descripción se refieren a una composición que comprende un anticuerpo inmunoterapéutico ligado operativamente a un péptido de afinidad de matriz extracelular (MEC). Un péptido de afinidad de MEC es uno que tiene afinidad por una proteína de matriz extracelular.
Bibliography:Application Number: MX20190012579